Tirzepatide Tirzepatide is a dual-action medication that activates both GLP-1 and GIP receptorstwo key hormones involved in metabolic regulation
Topical vs Injectable: Evidence Comparison The two delivery routes have fundamentally different evidence profiles: Topical GHK-Cu has decades of published clinical trial data for skin aging, wound healing, and hair density
Both forms support natural energy and metabolic wellness
Upon resuming after an extended pause, your prescriber might recommend restarting at your previously established dose, as your receptor sensitivity hasn't fundamentally changed
We recommend that you seek treatment in your 3rd trimester with your OB/midwife for any hydration or medication needs
Especially, one SNP was identified in both dominant and additive inheritance modes, which associates with low plasma DPP4 levels and which may increase the risk of MI in CAD patients (43)